Flow diagram of patient selection and subgroup classification. by Ningning Wang (560944)

Subjects:

Prevalence of low semen quality including 95% confidence interval (CI) for medication at the ATC 3 level. by P.G.J. ter Horst (21743830)

Subjects:

Multiple linear regression analysis of the RAAS system and glucose metabolism indexes in HT and NT patients. by Ningning Wang (560944)

Subjects:

The values of angiotensin II by Ningning Wang (560944)

Subjects:

Univariable and multivariable analyses (age-adjusted), concerning a selection of medicaments p < 0.1 and n ≥ 10. by P.G.J. ter Horst (21743830)

Subjects:

Spearman correlation matrix analysis of the RAAS system and glucose metabolism indexes at different hypertension subgroups. by Ningning Wang (560944)

Subjects:

Prevalence of low semen quality including 95% confidence interval (CI) for medication at the ATC 7 level. by P.G.J. ter Horst (21743830)

Subjects:

General characterization of T2DM patients and healthy controls. by Ningning Wang (560944)

Subjects:

Antihypertensive treatment of 151 T2DM patients with hypertension at different subgroups. by Ningning Wang (560944)

Subjects:

Spearman correlation matrix analysis of the RAAS system and glucose metabolism indexes at different normotension subgroups. by Ningning Wang (560944)

Subjects:

Characteristics of the study group. by P.G.J. ter Horst (21743830)

Subjects:

Univariable and multivariable analyses (age- and abstinence days-adjusted), concerning medicament(s) use and Low Semen Quality (LSQ). by P.G.J. ter Horst (21743830)

Subjects:

Spearman correlation matrix analysis of the RAAS system and glucose metabolism indexes in hypertensive (A) and normotensive (B) patients. by Ningning Wang (560944)

Subjects:

Prevalence of low semen quality including 95% confidence interval (CI) for medication at the ATC 5 level. by P.G.J. ter Horst (21743830)

Subjects:

Univariable and multivariable analyses (age- and abstinence days-adjusted), concerning a selection of medicaments with n ≥ 10 medicament users and p < 0.1 by univariate analysis.... by P.G.J. ter Horst (21743830)

Subjects:

Visual summary of metformin-associated ADRs in adolescents with T2D. by Mengsi Peng (12882734)

Joinpoint regression trends in age-standardized hospitalization and mortality rates of HPV-associated cancers in Mexico (2011-2019). by Juan Carlos Orengo (21546581)

Subjects:

Age distribution and median age at hospitalization and death by HPV-associated cancer type and sex, Mexico, 2011–2019. by Juan Carlos Orengo (21546581)

Subjects:

Forest plot of the association between vision impairment and difficulties with instrumental activity of daily living. by Masoud Rahmati (16665456)

Subjects:

DataSheet1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

“…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”